arrow
R

Ronald Boellaard

Cancer Center Amsterdam
H指数:92
被引数:4.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

PD-L1 PET/CT imaging with 18F-BMS-986,229 and 18F-BMS-986,192 in patients with advanced-stage non-small cell lung cancer

使用18F-BMS-986,229和18F-BMS-986,192对晚期非小细胞肺癌患者进行PD-L1 PET/CT成像

2026-09-290
PRE
A Lesion-adaptive Segmentation Approach for Tumor Delineation on FDG PET/CT in Diffuse Large B-cell Lymphoma Patients

一种适用于弥漫性大B细胞淋巴瘤患者FDG PET/CT肿瘤勾画的病灶自适应分割方法

2026-02-140
OAAI
Predicting 2-year time to progression in diffuse large B cell lymphoma using 3D CNNs on whole-body PET/CT scans

使用3D CNNs在全身PET/CT扫描上预测弥漫性大B细胞淋巴瘤的2年进展时间

2025-11-280
OAAI
Varying Levels of Inflammatory Activity in Brain and Body of Patients with Persistent Fatigue and Difficulty Concentrating After COVID-19: A TSPO PET Study
2025-11-010
PRE
Risk prediction in diffuse large B-cell lymphoma improves when combining baseline PET features with interim PET response

弥漫性大B细胞淋巴瘤的风险预测在结合基线PET特征与中期PET反应时得到改善。

2025-10-010
OAAI
Imaging Proinflammatory Microglia in Parkinson Disease Using [11C]SMW139 PET: A Multicenter Study

使用[11C]SMW139 PET成像帕金森病中的促炎性小胶质细胞:一项多中心研究

2025-10-010
PRE
Connectivity as a universal predictor of tau progression in atypical Alzheimer's disease

连接性作为非典型阿尔茨海默病中tau进展的通用预测因子。

BRAIN
IF11.7
2025-10-012
PRE
89Zr-mAb uptake interpretation requires the use of tissue to plasma ratios corrected for antibody catabolism

89Zr-mAb的摄取解释需要使用校正了抗体分解代谢的组织与血浆比率。

2025-09-260
OA
Can we obtain prognostic information from healthy tissue uptake and volume in baseline 18F-FDG PET/CT imaging in diffuse large B-cell lymphoma?

我们能否从弥漫大B细胞淋巴瘤的基线18F-FDG PET/CT成像中获取健康组织摄取和体积的预后信息?

2025-08-180
OA
Neuroinflammation at the Neuroforamina and Spinal Cord in Patients with Painful Cervical Radiculopathy and Pain-Free Participants: An [11C]DPA713 PET/CT Proof-of-Concept Study

神经根型颈椎病疼痛患者和无痛参与者的神经孔和脊髓神经炎症:一项[11C]DPA713 PET/CT概念验证研究

2025-04-020
OA
Measuring Total Metabolic Tumor Volume from 18F-FDG PET: A Reality Check

通过18F-FDG PET测量总代谢肿瘤体积:一次现实核查

2025-03-130
PRE